ليست عنوان مقالات لاتين P009 Baropodometric and stabilometric modifications after spasticity treatment with botulinum toxin in spinal cord injury patients Pacemaker and network mechanisms of rhythm generation: Cooperation and competition

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

P009 Baropodometric and stabilometric modifications after spasticity treatment with botulinum toxin in spinal cord injury patients

2

P01 Endothelial dysfunction in patients with peripheral obliterative artery disease is associated with hyperhomocysteinemia

3

P01. Auditory and electrically evoked brain stem reflexes in hemifacial spasm and postparalytic facial syndrome

4

P010 The influence of increased patellar tendon length on knee extension biomechanics during axial loading

5

P011 Functional degrees of freedom of neck movements: linear models may overestimate variability

6

P012 Example of exercise caloric pattern in a subject with cardiovascular risk

7

P013 Hand function assessment in patients with diabetes mellitus

8

P014 Variability in gait patterns – relationship between step variability, muscle strength and walking performance among children post brain injury

9

10

11

P015 The kinematics of gait of overweight and obese six-year-old children

12

13

P017 Effect of exercise training on dynamic posture performance of the head, neck, and shoulder in subjects with chronic neck pain

14

P018 Gait strategy study over time in diplegic children

15

P019 Perception and reproduction of whole body rotation in standing subjects

16

P02. Sound and vibration evoked vestibular potentials in the active masseter muscles of normal subjects

17

P020 Knee problems in girls with Turner syndrome – preliminary results

18

P021 The effect of botulinum toxin treatment on activity level of patients with spastic hemiparesis after stroke

19

P022 Using the Gillette Gait Index as a measure of congenital talipes equinovarus involvement

20

P023 Gait initiation analysis of a patient with Huntingtonʹs disease using wearable sensors for acceleration: a case study

21

P024 The effect of a functional strength training program on balance control in children with cerebral palsy

22

P025 The effect of a balance training program on dynamic postural control performance in adolescent with pes cavus

23

P026 Research on three degrees of freedom robot for upper limb rehabilitation

24

P027 Protection from over- or under-diagnosis of children with pes plano valgus by plantar pressure distribution

25

26

P029 Diagnostic usage of combined biomechanical gait and running-analysis

27

P03. Saccadic eye movement abnormalities in children with type 3 Gaucher disease are indicative for brainstem reticular formation pathology

28

29

30

P030 The development of walk ratio in normal children

31

P031 Assessment of absolute knee joint linear (LV) and angular velocity (AV) in patients with spastic cerebral palsy (CP) after operative treatment of lever arm dysfunction (LAD) deformities with and without distal rectus femoris muscle transfer

32

P032 May Schroth therapy improve reduced postural performance in adults with idiopathic scoliosis? Results from a pilot study

33

P033 Influence of cylindrical handle diameter and hand position on maximal grip force for young males and females

34

P034 Foot deformities classification through kinematics-kineticsplantar pressure data: cluster analysis.

35

P035 The effect of game speed on performance during core control training

36

P036 Influence of inverse dynamics on diabetic neuropathics joint kinetics estimation

37

P037 Strength outcome and progression over time following multilevel orthopaedic surgery in children with cerebral palsy

38

P038 Reproducibility of video screen measurement of sagittal joint and segment angles during gait in patients with spastic cerebral palsy

39

P039 Three-dimensional evaluation of knee function in anterior cruciate ligament-deficient and reconstructed knee

40

P04. Intermuscular coherence and eye movement studies in two sisters with orthostatic tremor

41

P040 Medial unicompartimental vs total knee arthroplasty patients performance during gait: a focus on muscular activity at the knee

42

P041 A comparison of two functional methods for calculating joint centers and axes in a clinical setting

43

P042 Comparison of electromyography in normal and simulated bowleg gait

44

P043 Measuring three-dimensional knee rotations with skin markers

45

46

P045 Reliability of a three-dimensional upper limb movement analysis in children

47

P046 Gait analysis of a novel design of total ankle replacement

48

P047 Natural history of flexed knee gait in diplegic cerebral palsy in children who have not received surgery

49

P048 Development of locomotion in the blind: step-time parameters (STP)

50

P049 Subject-specific hip joint centre location affects the calculation of hip contact forces during gait

51

P05 Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal and vasculopathic subjects

52

P05. Startle reactions to somatosensory inputs. Different response pattern to stimuli of upper and lower limbs

53

P050 Linear behavioral aspects of human postural sway

54

P051 Relation between upper limb function and neuroradiological findings in hemiplegic cerebral palsy

55

P052 Classification of gait patterns in chronic post stroke patients

56

P053 Accuracy requirements in BSIP estimations for analysis of normal gait

57

P054 Analysis of the influence of obesity on childrenʹs feet

58

P055 Dynamics of walking uphill and downhill in the group of women with diabetes mellitus

59

P056 Gait analysis of patients with a minimally invasive total hip arthroplasty compared to a standard THA in the early postoperative period

60

P057 Botulinum toxin and Froude number

61

P058 A certification scheme for the quality of kinematic data capture in gait analysis laboratories

62

P059 Can gait patterns in children with hemiplegic cerebral palsy be clustered into distinct clinically relevant groups?

63

P06. Holmes tremor of the head caused by a left midbrain astrocytoma

64

P060 Hemiplegic cerebral palsy: gait patterns and motor function across a population based cohort

65

P061 Evaluating the outcome of single event multilevel surgery: find the way use the MAP (movement analysis profile)

66

P062 Gait analysis in diabetic polyneuropathy

67

P063 The repeatability of observational gait analysis in clinical lower limb prosthetics

68

P064 The African disability scooter: for assisted ambulation

69

P065 Knee kinetics during walking at different speeds in patients who have undergone total knee replacement

70

P066 Transtibial amputees: does knee pain affect the gait pattern?

71

P067 Treadmill gait in diplegic cerebral palsy

72

P068 Standing exercise with lumbar vertebrae flexion improves walking speed of stroke patients in sequelae: a case report

73

P069 Differences of lower extremity isometric resistance in ambulatory diplegic and quadriplegic CP subjects

74

P07. Localized brainstem dysfunction in patients with Parkinson’s disease and central pain

75

76

P071 Does equinus cause pelvic retraction and increased internal femoral rotation in gait?

77

P072 Upper extremities joint angles in static positions

78

P073 Navigating through doorways with Parkinsonʹs disease

79

P074 Multilevel, high dose botulinum toxin type a treatment in ambulatory children with cerebral palsy.

80

P075 Analysis of the postural oscillation in obese children by means of stabilometric parameters

81

P076 Comparative electromyography analysis in TMD patients before and after physiotherapeutic treatment

82

P077 Upper limb injections of botulinum toxin type A in children with cerebral palsy: evaluation of treatment by goal attainment scaling

83

P078 Foot pressure profiles during gait can shed more light to the specific influence of dual-task among TBI patients

84

P079 Quantifying velocity-dependent gastrocnemius activity in spastic CP gait

85

P08. Pathophysiology of pain in postherpetic neuralgia. A clinical and neurophysiological study

86

P080 Gait patterns vary with walking speed

87

P081 Test–retest reliability of peak knee adduction moment in patients with osteoarthritis

88

P082 Comparison of kinematic results of Middle East Technical University custom made KISS and Ankara University commercial VICON gait analysis systems

89

P083 Genetic causes of hyperlipidaemia in a Malaysian population and their effects on the severity of the disease

90

P083 Interacting effects of walking speed and spasticity level on muscle-tendon length and velocity in children with cerebral palsy

91

P084 Effects of upper extremity motor recovery on gait pattern late after stroke

92

P085 Changes in clinical and biomechanical parameters in osteoarthritis knee patients after intraarticular infiltration with hyaluronic acid h.m.w.

93

P086 OAGAIT: an intelligent clinical decision support system based on quantitative gait data

94

P087 Manifestation of ataxia during gait in children: effect of concurrent-task

95

P088 The relationship between the height of the medial longitudinal arch (MLA) and the ankle and knee injuries in professional runners

96

P089 The relationship between selected parameters of computer tomography and biomechanical gait classification in post stroke patients

97

P09 Distribution and influence of apolipoprotein E (APOE) polymorphism on lipids in a sample of randomly selected population of Friuli-Venezia Giulia

98

P09. Trigeminal neuralgia in patients with multiple sclerosis: Quantitative MRI-neurophysiological correlations with a voxel-based 3D brainstem model

99

P090 Surface EMG as a diagnostic tool in diabetic neuropathy gait analysis

100

P091 Effect of lateral wedges on lower leg muscle length and potential for exacerbating spasticity

101

P092 Case studies to illustrate the use of the movement analysis profile (MAP)

102

P092 Relationship of pathologic coronary atherosclerotic lesions to serum cholesterol in young people in Isfahan/Iran

103

P093 Measurement of human kinematics using high speed camera

104

P094 The influence of self-modeling on learning beach volleyball reception skill

105

P095 The effects of rigid spinal orthosis on postural control of two healthy subjects

106

P096 Foot progression angles of 60 healthy Turkish children: normal values to guide management

107

P096 Hemodynamic evaluation of VBI

108

P097 Torsional deformities following pediatric femoral shaft fractures: compensatory mechanisms to restore foot progression angle

109

P098 Upper limb robot-assisted rehabilitation in children: movement performance measures

110

P099 Posture evaluation in obese patients: the role of weight and gender

111

P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors

112

P1- and VPg-transgenic plants show similar resistance to Potato virus A and may compromise long distance movement of the virus in plant sections expressing RNA silencing-based resistance

113

P1 Comparative study for the determination of HER2 geneamplification and overexpression in breast cancer

114

P1 Facteurs pronostiques dʹune série de 104 carcinomes canalaires in situ traités par chirurgie ou association radiochirurgicale

115

P1 Hydrogen transport through nickel hydroxide electro-deposited films

116

P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease

117

P1 The animal model for development of primary hormone therapy of breast cancer

118

P1, P2′-Linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors

119

P1,P4-Diadenosine 5′-Tetraphosphate Modulates l-Arginine and l-Citrulline Uptake by Bovine Aortic Endothelial Cells

120

P1. The expression of thyroid hormone receptors in human bone

121

P1/P0+ elements for incompressible flows with discontinuous material properties

122

P1′ oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1

123

P10 Bismuth compounds as cathodic material for lithium accumulators

124

P10 Can CISH bean alternative to FISH in the HER2/neu testing algorithm?

125

P10 Cancer du sein: traitement conservateur et curiethérapie peropératoire

126

P10 Effect of CYP2D6 and SULT1A1 genotypes on the serum concentration of 4-hydroxytamoxifen and 4-hydroxy-N-demethyltamoxifen during steady state treatment of breast cancer patients

127

P10 Effet thérapeutique majeur de lʹassociation de pentoxyfilline-tocophérol dans la fibrose radio-induite superficielle: essai de phase II

128

P10. A comparison of the mineral density of bone formed in vitro by rat osteoblasts with that formed in vivo

129

P10. Early responses to mechanical load in selectively-bred embryonic chicks differ

130

P10. Trigeminal sensory changes following gamma knife radiosurgery

131

P100 Comparison of short- versus long-segment instrumentation after torakolomber burst fractures in terms of gait deviations: a preliminary study

132

P100 The effect of flavonoids on the prevention of hemoglobin glycosylation

133

P100 Wave Latency and Amplitude in Visual Evoked Potential Records in Different Visual Quadrants of Normal Individuals

134

P100 Wave Latency in Anisometropic and Esotropic Amblyopia versus Normal Eyes

135

136

P102 Upper extremity kinematic analysis as a basis for surgical intervention: an OPBL case report

137

138

P104 Gait analysis of patients with hemiplegia using power spectrum of ground reaction force: difference between with and without ankle — foot orthosis

139

P105 A comparison of hamstring and patellar bone tendon autografts for ACL reconstruction in terms of quantitative gait data

140

P105 The difference in the impact of obesity indicators on blood pressure

141

P106 Association between clinical assessment and gait parameters in surgically treated idiopathic clubfoot

142

P107 In vivo reproducibility of fascicle length and pennation angle of gastrocnemius medialis muscle during human gait

143

P107 Oxidized low density lipoprotein (OXLDL) and lysophosphatidylcholine (lysoPC) could induce apoptosis of cultured vascular smooth muscle cells (VSMC)

144

P1075 opens mitochondrial KATP channels and generates reactive oxygen species resulting in cardioprotection of rabbit hearts

145

P108 Kinematic and kinetic gait characteistics after total meniscectomy

146

P109 Quantitative gait characteristics of patients with bipolar hip hemiarthroplasty

147

P11 Biologic behavior of E-cadherin in invasive ductal carcinoma

148

P11 Bronchiolite oblitérante avec pneumopathie en voie dʹorganisation (BOOP) compliquant une radiothérapie mammaire: 15 observations

149

P11 Expression of ALCAM/CD166 and related proteins inbreast cancer: tissue and cell lines

150

P11 Modelling and optimization of the parameters of the lithium/nonaqueous electrolyte interface in high energy power sources

151

P11. Bone morphometry and in situ hybridisation for the assessment of bone forming surfaces

152

P11. Impact of emotional stress on pain perception in an experimental pain model

153

P110 The comparison of the lower extremity kinematics in children with and without flexible flatfoot

154

P111 Classification of gait patterns in children with cerebral palsy

155

P112 Foot growth in Mongolian children between 12 and 17 years of age

156

P113 Comparing the exercise capacity by the results of exercise test in coronary patients before and after the cardiac rehabilitation

157

P113 The transtheoretical model of behavioral change to exercise in applying to adult Turkish people

158

159

160

P118 Psychiatric disorders and their relation to cardiovascular diseases

161

P12 Analysis of 25-hydroxyvitamin d3-1a-hydroxylase in normal and malignant breast tissue

162

P12 Comparaison de lʹeffet radiosensibilisateur in vitro de fludarabine entre une lignée cellulaire tumorale dʹun carcinome épidermoïde ORL (ZMK-1) et une lignée de cellules normales MRC5

163

P12 Lithium cobaltite. A supplierʹs point of view

164

P12 Metallothionein as a potential molecular target in breast cancer

165

P12 Rôle de lʹirradiation de la chaîne mammaire interne après mastectomie pour cancer du sein. Essai français collaboratif randomisé (SFBO)

166

P12. Cortical representation of experimental trigeminal pain in humans

167

P12. Identification of novel response genes in mechanically loaded articular cartilage: studies using differential display PCR

168

p120-Catenin Mediates Inflammatory Responses in the Skin

169

P123-stabilized Au–Ag alloy nanoparticles for kinetics of aerobic oxidation of benzyl alcohol in aqueous solution

170

P125 Bioavailability, serum and liver lipids are altered when rats are fed different doses of β-carotene in diets containing cholesterol and soybean oil or lard

171

P129 Garlic affects the lipid metabolism and antioxidative status while treated with various lipids containing diet in hamsters

172

P13 Analysis of lithium manganese oxide for lithium rechargeable batteries

173

P13 Association cancer du sein et lymphome malin: à propos de 26 cas

174

P13 Differential effects of doxorubicin treatment on the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells

175

P13 Induction of redifferentiation of breast cancer as therapeutic target using resveratrol

176

P13 kinase and not P42/P44 map kinase appears to be implicated in the protection conferred by ischemic preconditioning

177

P13 of Leucania separata multiple nuclear polyhedrosis virus affected the polyhedra and budded virions yields of AcMNPV

178

P13 Polymorphisms of the renin-angiotensin system in essential hypertension and nephroangiosclerosis

179

P13. Androgens are involved in the regulation of cancellous bone formation in female rats

180

P13. Compensation processes for central vestibular dysfunction in patients with acute medullary infarctions (FDG-PET study)

181

p130 expression in thyroid neoplasms: its linkage with tumor size and dedifferentiation

182

P130 Hemodynamic effect on the oxidant generation in cultured endothelial cells

183

P130Cas substrate domain is intrinsically disordered as characterized by single-molecule force measurements Original Research Article

184

P134 Prevalence of coronary and renal artery stenosis in patients with extracranial cerebral artery disease

185

P137 Safety, efficacy and feasibility of combined coronary, cerebral, renal and iliac angiogram performed in one sitting

186

P138 Abdominal aorta angiography: should it become a routine for patients with hypertension or renal impairment undergoing cardiac catheterisation?

187

P14 A study for cell cycle arrest and apoptosis induced by PPARr agonist in MDA-MB-231 breast cancer cells

188

P14 Curietherapie infusionnelle par le 32P colloïdal: études cliniques et bases expérimentales

189

P14 Development of a lithium-ion polymer battery for space power applications

190

P14 Radiochimiothérapie avec un protocole dʹirradiation hypo-fractionnée pour les cancers de vessie inopérables

191

P14 Tc-99m-(v)dmsa and tc-99m-sestamibiscintimammography in usual type ductal epithelial hyperplasia (uth) and apocrine metaplasia (am) of the breast — does radiotracer uptake relate to ki-67 and er profile and what this indicates about prognosis?

192

P14. Impaired balance with brain stem infarcts

193

P14. Long term variability of markers of bone turnover in healthy postmenopausal women

194

P140 Lipid lowering and hypouricemic action of micronized fenofibrate

195

P142 Usefulness of hemostatic marker in predicting survival after acute myocardial infarction

196

P145 Serum lipoproteins and metabolic control changes in various albuminuria stage of Taiwanese NIDDM patients

197

P148 A study of the effect of statin on the cerebrovascular atherosclerosis: regression of cerebral artery stenosis study

198

P15 Combined chemo-radiotherapy in the treatment of bladder carcinoma

199

P15 Interactions of tumorantigen-reactive T-cells derived from bone marrow and tumor-cells in breast cancer patients

200

P15 Le (E)-2′-déoxy-(fluorométhylène) cytidine (FMdC): un radiosensibilisateur et cytotoxique pour lʹapplication clinique?

201

P15 linicopathological features of breast cancer inwomen in different age groups

202

P15 Parallel cell arrangements for reserve lithium/ sulphuryl chloride batteries

203

P15. Aminohexane diphosphonate suppresses bone turnover in postmenopausal women more rapidly than oestrogen-gestagen therapy

204

P15. Exaggerated auditory startle responses in patients with spinal cord injury

205

P150 Lipid disorders in transitional societies

206

P1532, WAVES, and a New Initiative

207

p15Ink4b: Dual function in myelopoiesis and inactivation in myeloid disease

208

p16 (INK4^a, MTS-1) gene polymorphism and methylation status in human pituitary tumours

209

P16 Accessory breast carcinoma: a case report and review of the literature

210

P16 and p27 tumor suppressor gene methylation status in childhood Wilms tumor cases

211

P16 as a molecular biomarker of cervical adenocarcinoma

212

p16 expression in Barrettʹs esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations

213

P16 Fuel cells for vehicular applications — hydrogen storage and simulation aspects

214

p16 Gene Expression in Basal Cell Carcinoma

215

p16 gene methylation lacks correlation with angiogenesis and prognosis in multiple myeloma

216

p16 gene overexpression in mouse bladder carcinomas

217

p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis

218

P16 Modulation de lʹexpression de TGF-β et TNF-α dans la fibrose radio-induite cutanéomusculaire après traitement par lʹassociation de pentoxifylline et dʹalpha-tocophérol

219

P16 The effect of a cyclooxygenase-2 inhibitor on proliferating activity in breast carcinoma: first results

220

p16 tumor suppressor gene mutations in Chinese esophageal carcinomas in Hong Kong

221

P16 ةtude prospective des variations biologiques et cliniques au cours dʹune irradiation corporelle totale

222

P16. Differential regulation of osteoclast formation; interleukin 10 (cytokine synthesis inhibitory factor) suppresses formation of osteoclasts but not macrophages in murine bone marrow cultures

223

P16. Rare case of a skull-base meningioma

224

p16INK4A – alterations in primary angiosarcoma of the liver

225

p16INK4A and p14ARF tumour suppressors in melanoma: lessons from the mouse

226

p16Ink4a and p19Arf: terrible twins

227

P16INK4A Immunohistochemistry as a Gold Standard for Cervical Cancer and Precursor Lesions Screening

228

p16INK4a immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis

229

p16INK4a induces differentiation and apoptosis in erythroid lineage cells

230

p16INK4a promoter hypermethylation in oral scrapings of oral squamous cell carcinoma risk patients

231

p16INK4a/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?

232

P17 Association of age, gender, adiposity, menopause and diet with apo a defined HDL subfractions

233

P17 Comparison between the 5th and 6th American JointCommittee on Cancer (AJCC) staging system in 1,275 breast cancer patients

234

P17 Dosimétrie biologique et physique après irradiation corporelle totale: évaluation de la radiosensibilité individuelle de patients atteints dʹhémopathie maligne

235

P17 High performance membrane electrode assemblies for solid polymer fuel cells

236

P17 Le contenu intracellulaire et la nature des mélanines modifient la radiosensibilité des cellules de mélanome humain

237

P17 Letrozole (2.5 mg o.d.) is superior to anastrozole (1.0 mg o.d.) concerning suppression of both plasma and tissue estrogen levels in postmenopausal breast cancer patients

238

P17. Analysis of gene expression after mechanical stimulation of bone: C-fos expression is induced in osteocytes within 60 minutes of mechanical stimulation

239

P17. Pathological yawning in brainstem stroke

240

P18 Activity and stability tests in phosphotungstic acid electrolyte fuel cell

241

P18 Development of the Breast Cancer ProfileChipTM, anew diagnostic device dedicated to breast cancer

242

P18 Influence of the storage conditions on measurable uPA/PAI-1 protein levels in breast cancertissue specimen

243

P18 ةtude de la réparation de lʹADN, de la chromatine et de lʹapoptose en fonction de la radiosensibilité dans trois lignées de carcinomes humains

244

P18. Auditory evoked brain stem reflexes in peripheral facial paresis

245

P19 a Parthenin Analog Induces Cell Lineage Dependent Apoptotic and Immunomodulatory Signaling in Acute Lymphoid Leukemia Cells

246

P19 Association concomitante de radiothérapie et de chimiothérapie préopératoire des cancers rectaux: facteurs pronostiques de la réponse

247

P19 Fabrication of polymer based flexible electrodes for application in fuel cells

248

P19 Histological diagnosis of lesions of the female breast within 1 hour from core-cut-biopsies — a prospective study to compare breast imaging, rapid embedding and postoperative histological diagnosis

249

P19 La diminution des récepteurs du TGFβ est potentiellement impliquée dans la radiosensibilité des cellules de la gonade mâle

250

P19 Urinary estrogen metabolites and risk of breast cancer and epithelian ovarian cancer

251

P19. Nonlinear analysis of dynamic changes in brain spirography. Results in patients with ischemic stroke

252

P19. The effect of hepatocyte growth factor on the behaviour of isolated rat osteoclasts

253

p190 BCR-ABL Rearrangement in Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia

254

p19ARF Deficiency Reduces Macrophage and Vascular Smooth Muscle Cell Apoptosis and Aggravates Atherosclerosis

255

p19ras Represses proliferation of non-small cell lung cancer possibly through interaction with Neuron-Specific Enolase (NSE)

256

P1-reproducing shape-preserving quasi-interpolant using positive quadratic splines with local support

257

P2 Accumulator batteries and operation of electric vehicles

258

P2 Cancer du sein chez la femme âgée de 70 ans ou plus. Aspects anatomocliniques et thérapeutiques

259

P2 Intensive Hypermethylation of the CpG Island of Ras Association Domain Family 1A (RASSF1A) in tumour and non-tumorous tissue of breast cancer

260

P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffold

261

P2 Receptor for advanced glycation end products (RAGE) – Soluble form (sRAGE) and gene polymorphisms in patients with breast cancer

262

P2 receptors activation increases l-glutamate release in NTS neurons projecting to RVLM in rat brainstem slices

263

P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFα and potential role in myocardial cell death

264

P2. Expression of cytokines, growth factors and proto-oncogenes in renal bone disease: studies using reverse-transcription polymerase chain reaction (RT/PCR)

265

P20 Assessment of breast cancer tumor size depends onmethod, histopathology and tumor size itself

266

P20 Continuous production of gas diffusion electrodes for fuel cells by a filtration method

267

P20 Multidrug resistance-related protein and P-glycoprotein expression and washout rates of 99mTc-MIBI in infiltrating ductal carcinoma of breast

268

P20 Pulsed dose rate and low dose rate brachytherapy. In vitro assays comparing effects of dose and dose rate per pulse in a radiosensitive and radioresistant cell line

269

P20 Tolérance de lʹassociation carbogène-nicotinamide dans le traitement des glioblastomes inopérables par irradiation et chimiothérapie

270

P20. Botulinum toxin treatment has no influence on auditory startle reaction in primary blepharospasm

271

P20. Evaluation of an interactive image analysis system for the quantification of cortical and cancellous bone in the human femoral neck

272

P21 (Waf1/Cip1) Gene Polymorphisms and Possible Interaction with Cigarette Smoking in Esophageal Squamous Cell Carcinoma in Northeastern Iran: A Preliminary Study

273

P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth

274

P21 Classification and characterisation of primary batteries: Part 1: Standardised conditions for the experimental determination of performance characteristics

275

p21 Expression by human urothelial carcinoma cells modulates the phenotypic response to BCG

276

p21 expression is a prognostic factor in patients with p53-negative gastric cancer

277

P21 Facteurs influençant les variations à long terme de lʹépaisseur cutanée du sein après irradiation pour carcinome

278

p21 gene codon 31 polymorphism is associated with bladder cancer

279

P21 Relationship between serum lipids profile, apolipoproteins pattern and severe coronary artery disease angiographically documented

280

P21 Semiquantitative analysis of diffuse pattern of 99mTc-V-DMSA scintimammography in the evaluation of in situ breast carcinomas: A feasible prognostic marker?

281

p21 stability: Linking chaperones to a cell cycle checkpoint

282

P21 Subclassification of BIRAD category 4 microcalcification according to morphologic difference – more accurate method to detect DCIS or breast cancer

283

P21. Collagen metabolism in mineralizing tendon

284

P21. The somatosensory blink reflex in Guillain–Barré polyneuritis, Miller–Fisher’ syndrome and Bickerstaff’s brainstem encephalitis

285

P21-activated kinase 1 promotes colorectal cancer survival by up-regulation of hypoxia-inducible factor-1α

286

p21Cip1 Confers resistance to imatinib in human chronic myeloid leukemia cells

287

p21Cip1/Waf1/Sdi1 protects against hyperoxia by maintaining expression of Bcl-XL

288

p21Waf1/Cip1 as a therapeutic target in breast and other cancers

289

P22 Breast cancer screening of Korean women

290

P22 Classification and characterisation of primary batteries: Part 2: System and performance characteristics and their application to matters of safety and nomenclature

291

P22 Efficacy of combination Mammotome biopsy with mammography guided needle localization for clustered microcalcifications

292

P22 Radiosensibilité des carcinomes centropelviens du col utérin de diamètre supérieur à 4 cm. ةtude des facteurs pronostiques de la réponse tumorale

293

P22 Variations dʹexpression de trois gènes dans une lignée cellulaire tumorale ORL après irradiation gamma

294

P22. Reinnervation activity in the unaffected facial nerve after complete unilateral peripheral facial palsy

295

P22. Standards for backscattered electron (BSE) imaging of skeletal and dental tissues

296

P23 Détection des dommages radio-induits de lʹADN dʹune lignée cellulaire monocytaire humaine: étude comparative entre la technique Comète et lʹanalyse chromatographique

297

P23 Hypermethylation of E-cadherin, GSTP1, 14-3-3σ and TIMP-3 genes as prognostic markers in invasive ductal breast carcinoma

298

P23 Identification de gènes marqueurs de radiosensibilité dans le modèle de la gonade mâle

299

P23 The development of a multi-purpose battery information system

300

P23 What kind of calcified lesion can be diagnosed as ductal carcinoma in situ (DCIS) exactly by needle biopsy?

301

P23. Large demyelinating lesion of the pons as a cause of a locked-in syndrome in multiple sclerosis

302

P23. Ultrasound of the os calcis in post menopausal diabetic women

303

P24 A poptose radio-induite dans une lignée humaine de carcinome indifférencié du nasopharynx: implication du système Fas/ Fas ligand

304

P24 Evaluation of lithium primary cells for long-life applications

305

P24 Predictive value of p53 and Her-2/neu proteins inpatients with breast cancer

306

p24 proteins, intracellular trafficking, and behavior: Drosophila melanogaster provides insights and opportunities

307

P24 Radiothérapie première suivie dʹune chirurgie dʹexérèse dans les cancers épidermoïdes du col utérin de stade I et II de gros volume

308

P24 X-ray microscopic imaging of female breast tissues by synchrotron radiation

309

P24. Classical brain stem syndromes: Myth or reality?

310

P25 Cardiovascular risk factors in the elderly: The “Fossalta” study

311

P25 HER2 Testing in 538 consecutive breast cancer cases using immunohistochemistry and fluorescence in situ hybridization

312

P25 niblet-like coated on large void space TiO2 nanotubes arrays for high-rate charge-collection and improved photoconversion efficiency

313

P25 Safe and efficient charging algorithm for lithium batteries

314

P25 Tumorectomie après irradiation première dans les cancers du sein mesurant plus de 3 cm. Réponse histologique et suivi

315

P25 Use of N-terminal brain natriuretic peptide as a predictive marker for chemotherapy-induced cardiotoxicity

316

P25 ةtude de lʹapoptose après irradiation de lignées cellulaires adhérentes

317

P25. Rates of resorption of live vs devitalized bone in vitro: significance for bone grafts

318

P25. Sensitivity of imaging and electrophysiological brainstem testing in the diagnosis of acute vertebrobasilar ischemia

319

P25/graphene nanocomposites as a high-performance anode material for lithium ion batteries

320

P26 Gene expression profiles can predict pathologiccomplete response to preoperative chemotherapy with gemcitabine, epirubicin and docetaxel in primary breast cancer

321

P26 HER-2 overexpressed breast cancer and brain metastases

322

P26 Implication du céramide dans la réponse à lʹirradiation (10 Gy) de lignées cellulaires adhérentes

323

P26 Radiothérapie primaire ou chirurgie combinée (ou non) à une irradiation dans le traitement du cancer du pénis

324

P26 The morphology of microporous polyethylene separators and its significance for the performance of lithium batteries

325

P26. Daily feeding with gamma linolenic acid (GLA) affects early load-related responses in vitro

326

P26. Forehead-taps can evoke normal leg-muscle evoked postural reflexes in bilateral vestibulopathy

327

p27 as a target for cancer therapeutics

328

p27 expression as a prognostic factor of breast cancer in Taiwan

329

P27 Expression of “basal” cytokeratins in early (pT1) ductal infiltrating carcinoma

330

P27 Model of a powerful high-temperature primary battery

331

p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2

332

P27 Promotes TGF-β-Mediated Pulmonary Fibrosis via Interacting with MTORC2

333

P27 Radiothérapie conformationnelle des cancers bronchiques inopérables. Technique et méthodologie prédictive du contrôle local et des complications chez 82 patients

334

P27 Radiothérapie externe focalisée après résection de métastase cérébrale unique: étude prospective de phase I–II

335

P27 The role of HER-2 overexpression as a predictive factor to neoadjuvant, anthracycline-containing chemotherapy in locally-advanced breast cancer (LABC)

336

P27. A novel technique for the measurement of ultrasonic properties in small bone specimens in vitro

337

P27. Choice reaction times for human head rotations are shortened by startling acoustic stimuli, irrespective of stimulus direction

338

p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function

339

p27Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma

340

p27Kip1-stathmin interaction influences sarcoma cell migration and invasion

341

P28 Breast cancer characteristics in very youngpremenopausal, high-risk women, aged up to 35

342

P28 Electron transfer in the molten salt systems: CuCl-CuCl2-LiCl and CuCl-CuCl2-NaCl

343

P28 Experience of mammotome excision of benign breast disease in Korea

344

P28 Radiothérapie conformationnelle des cancers bronchiques inopérables. Prise en compte des mouvements respiratoires

345

P28 Radiothérapie externe dans le traitement de la dégénérescence maculaire liée à lʹâge (DMLA)

346

P28. Variability of individual lumbar vertebral Z scores

347

P29 A new one-step nucleic acid amplification (OSNA) with cytokeratin (CK)19 mRNA for intra-operative detection of lymph node (LN) metastasis in breast cancer patients: results from the Multi-institutional Clinical Study

348

P29 Age does affect the HER-2/neu status of breast cancers

349

P29 High temperature lithium storage battery with an electron-conducting CuCl-CuCl2 melt as cathodic material

350

P29 Questionnaire satisfaction des patients (QSP) dans un service de radiothérapie (RT): étude de faisabilité chez 40 patients (pts) traités au centre Henri-Becquerel (CHB)

351

P29 ةtude in vitro de lʹassociation vinorelbine-radiothérapie

352

P29. The measurement of pyridinium crosslinks in serum as a biochemical marker of bone turnover in horses

353

P2-achiral, Pʹ-extended α-ketoamide inhibitors of calpain I

354

P2-CONNECTEDNESS IN L-TOPOLOGICAL SPACES

355

P2O5/Al2O3 as an efficient heterogeneous catalyst for chemoselective synthesis of 1,1-diacetates under solvent-free conditions

356

P2O5/Al2O3 as an effieient catalyst for one-pot synthesis of polyhydroquinoline derivatives under solvent-free conditions

357

P2O5/SiO2 as an Efficient and Recyclable Catalyst for N-Acylation of Sulfonamides under Heterogeneous and Solvent-free Conditions

358

P2P collaborative filtering with privacy

359

P2P commercial digital content exchange

360

P2P Computing Systems

361

P2P Network Trust Management Survey

362

P2P Networks and the Verizon v. RIAA Case: Implications for Personal Privacy and Intellectual Property

363

P2P Object-based adaptivE Multimedia Streaming (POEMS)

364

P2P OLAP: Data model, implementation and case study

365

P2P reputation management: Probabilistic estimation vs. social networks

366

P2P searching trends: 2002–2004

367

P2–P3 conformationally constrained ketoamide-based inhibitors of cathepsin K

368

P2–P4 Macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease

369

p2pDating: Real life inspired semantic overlay networks for Web search

370

P2-proline-derived inhibitors of calpain I

371

P2X1 receptor currents after disruption of the PKC site and its surroundings by dominant negative mutations in HEK293 cells

372

P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium

373

P2X2 and P2X3 receptor expression in the gallbladder of the guinea pig

374

P2X2 receptor expression by interstitial cells of Cajal in vas deferens implicated in semen emission

375

P2X3 receptor subunit messenger RNA expression in the female mouse bladder after oophorectomy with or without estrogen replacement

376

P2X7 polymorphism and chronic lymphocytic leukaemia

377

P2X7 polymorphism and chronic lymphocytic leukaemia

378

P2X7 purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability

379

P2X7 receptor expression levels determine lethal effects of a purine based danger signal in T lymphocytes

380

P2X7 subunit-like immunoreactivity in the nucleus of visceral smooth muscle cells of the guinea pig

381

P2Y purinergic receptors regulate the growth of human melanomas

382

P2Y receptors activated by diadenosine polyphosphates reestablish Ca2+ transients in achondroplasic chondrocytes

383

P2Y1 receptor antagonists as novel antithrombotic agents

384

P2Y12 inhibition after thrombotic thrombocytopenic purpura remission

385

P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjِgrenʹs syndrome

386

P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption

387

P3 amplitude and time-on-task effects in distractible adolescents

388

P3 amplitude reduction and executive function deficits in men convicted of spousal/partner abuse

389

P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors

390

P3 approach to intersection–union testing of hypotheses

391

P3 cap modified Phe*-Ala series BACE inhibitors

392

P3 Evaluating the expression of HMGCS2 in human breast cancer relapses

393

P3 event-related potentials and childhood maltreatment in successful and unsuccessful psychopaths

394

P3 Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas

395

P3 scalp topography to target and novel visual stimuli in children of alcoholics

396

P3 The calculated discharge curve

397

P3 topographical change with task familiarization and task complexity

398

P3 Traitement radiochirurgical conservateur dans le cancer du sein PT1 inférieur ou égal 10 mm, N-, sans traitement médical adjuvant: résultats à 9 ans chez 295 patientes

399

P3. Clinical evaluation of a radioimmunoassay for the measurement of deoxypyridinoline in urine and serum

400

P30 Investigation aimed at development of a high-temperature lithium/air storage battery

401

P30 Les dysgerminomes du système nerveux central. Expérience du service de radiothérapie de lʹhôpital Saint-André de Bordeaux

402

P30 Radiothérapie des cancers bronchiques non à petites cellules localement évolués: résultats portant sur une série de 266 patients

403

P30 The role of HER-2/neu and estrogen receptors in theresponse to tamoxifen and prognosis in women with breast cancer

404

P300 after head injury: Pseudodelay caused by reduced P3A amplitude

405

P300 amplitude decrements in children from families of alcoholic female probands

406

P300 amplitude in subjects with primary insomnia is modulated by their sleep quality

407

P300 amplitude is related to clinical state in severely and moderately ill patients with schizophrenia

408

P300 amplitude reduction in schizophrenia: An endophenotype or an illness indicator?

409

P300 and blink instructions

410

P300 and response time from a manual Stroop task

411

P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia

412

P300 as an index of attention to self-relevant stimuli

413

P300 assessment of opiate and cocaine users: Effects of detoxification and buprenorphine treatment

414

P300 changes in major depressive disorders with and without psychotic features

415

P300 Component Modulation During a Go/Nogo Task in Healthy Children

416

P300 correlates of inspection time

417

P300 decrements in teenagers with conduct problems: implications for substance abuse risk and brain development

418

P300 deficits are present in young first-episode patients with schizophrenia and not in their healthy young siblings

419

P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication

420

P300 Detection Based on EEG Shape Features

421

P300 development during adolescence: Effects of DRD2 genotype

422

P300 differences between sinistrals and dextrals

423

P300 Evoked Potential in Patients with Mild Cognitive Impairment

424

P300 in the differentiation of Alzheimerʹs disease and depression

425

p300 Interacts with the Nuclear Proto-Oncoprotein SYT as Part of the Active Control of Cell Adhesion

426

P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder

427

P300 recordings during event-related fMRI: a feasibility study

428

P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology

429

P300 Subcomponent Abnormalities in Schizophrenia: II. Longitudinal Stability and Relationship to Symptom Change

430

P300 subcomponent abnormalities in schizophrenia: III. Deficits in unaffected siblings of schizophrenic probands

431

P300 subcomponents in obsessive-compulsive disorder

432

P300 subcomponents reflect different aspects of psychopathology in schizophrenia

433

P300 to high intensity stimuli during REM sleep

434

P300 topography differs in schizophrenia and manic psychosis

435

P300 Wave Changes in Patients with Multiple Sclerosis

436

P300, a state and a trait marker in schizophrenia

437

P300, Alcoholism Heritability, and Stimulus Modality

438

P300-based brain computer interface: Reliability and performance in healthy and paralysed participants

439

p300-Catalyzed Lysine Crotonylation Promotes the Proliferation, Invasion, and Migration of HeLa Cells via Heterogeneous Nuclear Ribonucleoprotein A1

440

P-31 changes as a measure of therapy response in resistant and sensitive osteosarcomas implanted into nude mice

441

P31 Coagulation indicators in patients with paroxysmal atrial fibrillation: Effect of electrical and pharmacological cardioversion

442

P31 Does HER2/neu expression on the primary tumor of breast cancer patients predict the phenotype of minimal residual disease?

443

P31 Intra-operative rapid molecular diagnostic method for the detection of lymph node metastases in breast cancer

444

P31 Irradiation fractionnée des neurinomes de lʹangle pontocérébelleux de stade III ou IV. Résultats à long terme

445

P31 Radiochimiothérapie dans les cancers bronchiques non à petites cellules

446

P31. Presence of non-adherent osteoprogenitors in cultures of human bone marrow

447

p31comet Blocks Mad2 Activation through Structural Mimicry

448

P32 Axillary lymph node involvement in breast cancer decreases with age but increases again after age 70 mainly in small tumors

449

P32 Cancer du larynx chez la femme

450

P32 Clodronate influence on the prediction ofchemotherapy effectiveness in patients with primary breast cancer

451

P32 Néovaisseaux sous-rétiniens rétrofovéolaires (NVSR) et radiothérapie: évaluation 2 ans après le traitement

452

P32. Relationship of bone mineral density to age in men

453

P33 A comparative study on the value of FDG-PET & SNB to identify axillary metastases

454

P33 Breast Cancer in Women with Recent Exposure to Fertility Medications is Associated with Poor Prognostic Features

455

P33 Hyperthermie interstitielle et curiethérapie dans le traitement conservateur du cancer du sein

456

P-33 Neuronal nos contributes to bradykinin-induced coronary flow in endothelial NOS knockout (eNOS-KO) mice

457

P33 Traitement palliatif du carcinome bronchique non à petites cellules: étude de phase I de radiothérapie hypofractionnée et de chimiothérapie concomitante

458

P33. Cytokine-induced bone resorption in mouse osteoclast cultures; differences between IL-1 and TNFα

459

P33. Cytokine-induced bone resorption in mouse osteoclast cultures; differences between IL-1 and TNFα

460

P34 Alternative method for the diagnosis of early breast cancer using plasma free amino acid profiles

461

P34 Galectin-9 is a possible prognostic factor withanti-metastatic potential for breast cancer

462

P-34 Inhibitory effects of ursodeoxycholic acid (UDCA) on the induction of nitric oxide synthase (iNOS) in vascular smooth muscle cells (VSMCs)

463

P34 Métastases cérébrales des carcinomes bronchiques non à petites cellules (CBNPC): analyse dʹune série rétrospective de 95 cas

464

P34 Tumeurs de la granulosa de lʹovaire. ہ propos de neuf cas

465

P34. Effects of prostaglandin E2 (PGE2) on proliferation, 25-hydroxyvitamin D-24-hydroxylase activity and vitamin D receptor (VDR) number in adherent-HL60 cells

466

P35 Analyses of serum samples from breast cancer patients using a novel biomarker assay

467

P-35 Effect of angiotensin-converting enzyme inhibition on gene expression in vascular smooth muscle cell

468

P35 Impact sur la survie et la probabilité de rechute de la radio- I thérapie effectuée après autogreffe de cellules souches hématopoïétiques chez des patients atteints dʹun lymphome malin non hodgkinien. Expérience de lʹhôpital Saint-Antoine

469

P35 Nail fold capillaroscopy in the study of microcirculation of isolated systolic hypertension (ISH) and systolic-diastolic hypertension (SDH) in elderly

470

P35 Prognostic Relevance of Activation of pAkt and pMAPK In Node-Negative Breast Cancer

471

P35 Traitement des cancers bronchiques non à petites cellules: expérience tunisienne

472

P35. Changes in tenascin distribution are associated with rachitic lesions: localisation studies in vitamin D-deficient chick and hyp mouse bone

473

P36 Acceptation de la colostomie en milieu marocain: à propos dʹun sondage dʹopinion

474

P36 Assessment of bone metastases using bone scan and PET/CT imaging in patients with breast cancer

475

P-36 Gene transfection of NF-KB decoy oligonucleotides improves vascular permeability in septic mouse lung

476

P36 Métastases cérébrales inopérables de carcinome bronchique non à petites cellules. Association chimioradiothérapie cérébrale séquentielle ou concomitante: étude de phase III

477

P36 Persistence of isolated tumor cells (ITC) in bonemarrow (BM) of breast cancer patients predicts increased risk for relapse

478

P36. Biomechanical and biochemical changes in cortical allograft bone after gamma irradiation

479

P37 A comparative study of cyclooxygenase-2 expression in Korean and Caucasian patients with early-onset breast carcinoma

480

P37 Adénocarcinome du rectum: rechutes locorégionales traitées par irradiation associée ou non à une chirurgie

481

P37 Relevance of radial scar and breast cancer; pathologic and radiologic findings in 30 cases

482

P-37 The effect of secretary leukocyte protease inhibitor on experimental autoimmune myocarditis

483

P37. Mechanical load causes adaptive changes in modelling drifts in vivo to adjust whole bone architecture

484

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents

485

P38 Detection of angiogenic micrometastases in the drainage vein of breast by using RT PCR

486

P-38 Exercise and food-restriction improved the levels of plasma adipocytokines and growth hormone in obese women

487

p38 Inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells

488

p38 Inhibitors: piperidine- and 4-aminopiperidine-substituted naphthyridinones, quinolinones, and dihydroquinazolinones

489

p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas

490

p38 MAP kinase activation mediates γ-globin gene induction in erythroid progenitors

491

p38 MAP kinase controls EGF receptor downregulation via phosphorylation at Ser1046/1047

492

p38 MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold

493

p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones

494

p38 MAP kinase inhibitors. Part 5: Discovery of an orally bio-available and highly efficacious compound based on the 7-amino-naphthyridone scaffold

495

p38 MAP kinase inhibitors. Part 6: 2-Arylpyridazin-3-ones as templates for inhibitor design

496

p38 MAP kinase inhibitors: Metabolically stabilized piperidine-substituted quinolinones and naphthyridinones

497

p38 MAP kinase is differently distributed and activated in the atria and ventricle of the anoxic-reoxygenated developing heart

498

p38 MAP kinase regulates benzo(a)pyrene-induced apoptosis through the regulation of p53 activation

499

p38 Map Kinase Substrate Specificity Differs Greatly for Protein and Peptide Substrates

500

p38 MAP kinase: a convergence point in cancer therapy

501

p38 MAPK activation restores cardioprotection to the aged heart

502

p38 MAPK Activation Triggers Pharmacologically-induced β -adrenergic Preconditioning, but Not Ischaemic Preconditioning

503

p38 MAPK activation: trigger or ediator in ischaemic preconditioning(PC)?

504

p38 MAPK Activity is Not Increased Early During Sustained Coronary Artery Occlusion in Preconditioned Versus Control Rabbit Heart

505

p38 MAPK and apoptosis in pacing-induced heart failure in rabbits

506

p38 MAPK and NF-κB pathways are involved in naphtho[1,2-b] furan-4,5-dione induced anti-proliferation and apoptosis of human hepatoma cells

507

p38 MAPK and PI3K/AKT Signalling Cascades in Parkinson’s Disease

508

p38 MAPK appears to be involved in the cytoprotective effect of insulin therapy administrated at reperfusion

509

p38 mapk associated with stereoselective priming by grepafloxacin on o2− production in neutrophils

510

p38 MAPK contributes to CD54 expression and the enhancement of phagocytic activity during macrophage development

511

p38 MAP-kinase regulates function of gap and tight junctions during regeneration of rat hepatocytes

512

p38 Mitogen Activated Protein Kinase Mediates Both Death Signaling and Functional Depression in the Heart

513

p38 mitogen-activated kinase (MAPK) is essential for equine neutrophil migration

514

p38 mitogen-activated kinase (MAPK) is essential for equine neutrophil migration

515

p38 mitogen-activated protein kinase (MAPK) first regulates filamentous actin at the 8–16-cell stage during preimplantation development

516

p38 Mitogen-activated protein kinase (p38 MAPK) and NADPH Oxidase (NOX) are cytoprotective determinants in the trophozoite-induced apoptosis of peripheral blood mononuclear cells

517

p38 mitogen-activated protein kinase inhibition attenuates burn-induced liver injury in rats

518

p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat Original Research Article

519

p38 Mitogen-Activated Protein Kinase: A Future Target for Heart Failure Therapy?

520

P38 Periodical mammographic screening influences stage and outcome in breast cancer patients, on a population-based observation. Results of the Italian NORA study

521

P38 Radiothérapie du mycosis fongoïde: lʹexpérience de lʹhôpital Henri-Mondor

522

P38 Sérologie des maladies sexuellement transmissibles (MST) et néoplasie du col utérin

523

p38(beta)-MAPK mediated cardioprotection by carbon monoxide (CO) in the isolated mouse heart

524

P38. Modulation of alkaline phosphatase expression in human bone marrow stromal fibroblasts and MG 63 cells by 5-azacytidine

525

P38-associated pathway involvement in apoptosis induced by photodynamic therapy with Lonicera japonica in human lung squamous carcinoma CH27 cells

526

p38-MAPK and PKB/Akt, possible role players in red palm oil-induced protection of the isolated perfused rat heart?

527

p38MAPKδ controls c-Myb degradation in response to stress

528

p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis

529

p38α MAP Kinase C-Terminal Domain Binding Pocket Characterized by Crystallographic and Computational Analyses

530

p38α MAP Kinase Dimers with Swapped Activation Segments and a Novel Catalytic Loop Conformation

531

p38β2-Mediated Phosphorylation and Sumoylation of ATF7 Are Mutually Exclusive

532

p38δ and PKD1: Kinase Switches for Insulin Secretion

533

P39 Age-group specific mammography coverage in the Hungarian nation-wide organized breast cancer screening programme

534

P-39 Anti-thrombotic properties of heme oxygenase-1 via the suppression of reactive oxygen species

535

P39 Carotid stenosis and the role of non-lipid factors

536

P39 Expérience dʹun réseau informatique reliant différents systèmes en radiothérapie

537

P39 La radiothérapie postopératoire du cancer de lʹutérus

538

P39 Survival of postmenopausal metastatic breast cancerpatients in relation to plasma TGF-betal

539

P39. The influence of parathyroidectomy (PTX) and ovariectomy (OVX) upon matrix metalloproteinases within rat trabecular bone

540

P3a and P3b from typical auditory and visual stimuli

541

P3a from a passive visual stimulus task

542

P3a from auditory white noise stimuli

543

P3a, perceptual distinctiveness, and stimulus modality

544

P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma

545

P3HT/PCBM bulk heterojunction solar cells: Relation between morphology and electro-optical characteristics

546

P3HT/TiO2 bulk-heterojunction solar cell sensitized by a perylene derivative

547

P3HT/ZnO bulk-heterojunction solar cell sensitized by a perylene derivative

548

P3HT/ZnS: A new hybrid bulk heterojunction photovoltaic system with very high open circuit voltage

549

P4 and P1′ optimization of bicycloproline P2 bearing tetrapeptidyl α-ketoamides as HCV protease inhibitors

550

P4 cap modified tetrapeptidyl α-ketoamides as potent HCV NS3 protease inhibitors

551

P4 Estrogen receptor isoforms in breast cancer: possible role in tamoxifen resistance

552

P4 Evaluation of Msh2, MIh1, Brca1 and Fhit proteinexpression in T1 NO MO breast cancer

553

P4 New achievements in the cycle life of the silver/zinc battery

554

P4 Récidives locales après traitement conservateur des cancers du sein. Fréquence, modalités de découverte, possibilités thérapeutiques et pronostic

555

P4. Transcriptional inhibition of the erythropoetin (EPO) gene by raised extracellular calcium: role of the negative calcium response element

556

P-40 Assessment of dissociation ability of several 5-HT2 antagonists in muscarinic receptor of rat heart

557

P40 Cataracte après irradiation corporelle totale (ICT) et greffe de moelle osseuse pour leucémie aiguë en rémission complète (RC): étude du fichier européen des greffes de moelle osseuse (EBMT: European Bone Marrow Transplantation)

558

P40 Dosimétrie et fonctionnement de lʹaccélérateur ≪ primus≫

559

P40 Erythropoietin (EPO) and its receptors (EPOR) detection in human breast cancer specimens: correlation with steroid receptors (membrane intracellular) and other biological and clinical indices

560

P40 Pooled analysis (n=8,377) validates predictive impactof uPA and PAI-1 for response to adjuvant chemotherapy in breast cancer

561

P40. Reconstruction of the forming site in renal osteodystrophy

562

p40phox: The last NADPH oxidase subunit

563

P41 High preoperative CA15-3 and CEA concentrationscan predict a poor outcome in breast cancer

564

P41 Irradiation cérébrale chez la femme enceinte: réduction de la dose fœtale par modification de la position

565

P-41 Signaling mechanisms of urotensin II in the smooth muscle contraction

566

P41 Significant improvement in breast cancer survival through population-based mammography screening for women aged 40–49 years in Turku, Finland

567

P41 ةtude médico-économique de la curiethérapie à bas débit pulsé (PDR) versus à bas débit continu (LDR)

568

P41. Effects of antioxidants on the proliferation and differentiation of human bone marrow stromal fibroblastic cells

569

P42 Before MRI what? Treatment and follow-up of patients who underwent breast conservative surgery for breast cancer without preoperative MRI evaluation

570

P42 The age-related ER+PR+ expression differs by HER-2/neu status

571

P-42 The role of Na+/H+ exchange in the angiotesin II induced negative inotropic effect in indo-1 loaded adult mouse ventricular myocytes

572

P42 Traitement par neutron des cancers de la prostate: quelle place ?

573

P42. Familial hypoparathyroidism?

574

P43 Acute phase proteins and lipidic pattern in patients with acute myocardial infarction (AMI) within a week from the occurrence

575

P43 Assessment of the Prognostic Value of HER2 ReceptorExpression in patients Treated for Breast Carcinoma

576

P43 Carcinome embryonnaire pur de lʹovaire. ہ propos de trois cas

577

P-43 Inotropic effects of growth hormone-releasing peptide-2: Cross-talk with catecholamine

578

P43 Radiothérapie externe par électrons des lésions rétrofovéo-laires de la dégénérescence maculaire liée à lʹâge

579

P43 The validity of complex breast cysts after surgery

580

P43. Monoclonal antibodies that recognise human type V tartrate resistant acid phosphatase

581

P44 Is tumor-biological risk-assessment realistic in node-negative breast cancer? A status report of the ongoing clinical multicenter trial NNBC-3-Europe

582

P44 NNBC-3 Europe: A prospective clinical trial on riskestimation and optimization of adjuvant chemotherapy in node-negative breast cancer patients

583

P44 Plésiocuriethérapie des mélanomes de la choroïde: 50 patients traités à Gِttingen de 1991 à 1997

584

P44 Prototype de simulation virtuelle intégrée de radiothérapie basée sur une technologie de scanographie pour la planification et la mise en route dʹune radiothérapie conformationnelle tridimensionnelle (RTC-3D)

585

P44. Cytokine production by human osteoblasts mechanically deformed on flexible petri dishes

586

P45 Apport de la tomodensitométrie dans lʹévaluation de la distribution de dose en curiethérapie gynécologique

587

P45 Dégénérescence maculaire liée à lʹage (DMLA): technique dʹirradiation par un faisceau de protons de 65 MeV

588

P45 Impact of lymphoid infiltration of tumor on survival ofyoung patients with breast cancer

589

P45 Risk factors of bone metastases in early breast cancer

590

P45. Review of 7 patients with type 1 osteogenesis imperfecta, treated with HRT or bisphosphonate

591

P450 2E1 expression in liver, kidney, and lung of rats treated with single or combined inducers

592

P450 Gene Induction by Structurally Diverse Xenochemicals: Central Role of Nuclear Receptors CAR, PXR, and PPAR

593

P450 oxidoreductase deficiency

594

P450BM-3: Absolute Configuration of the Primary Metabolites of Palmitic Acid

595

P450-Catalyzed In-Chain Desaturation of Valproic Acid: Isoform Selectivity and Mechanism of Formation of Δ3-Valproic Acid Generated by Baculovirus- Expressed CYP3A1

596

P450s in Microbial Sterol Biosynthesis and Drug Targets

597

P450SCC-Dependent Cholesterol-Metabolism in Rat Adrenal Mitochondria Is Inhibited by Low Concentrations of Matrix Ca2+ 1

598

P46 Patterns of recurrence and prognosis in women with basal-like breast cancer

599

P46 Therapeutic results of breast conserving surgery

600

P46 Traitement de la douleur cancéreuse: expérience tunisienne

601

P46. Vitamin D treatment modulates the sensitivity of leukaemic blasts to monocyte-mediated killing

602

P47 Breast conservation treatment in women with locallyadvanced breast cancer

603

P47 Curietherapie des carcinomes cutanés de la face: série rétrospective du CHU de Grenoble

604

P47 Management of risk factors in diabetic patiens: gap between recommendations and practice

605

P47 Prognosis of breast cancer patients with micrometastatic sentinel lymph nodes

606

P47 ةvolution du traitement conservateur du cancer du sein en Tunisie

607

P47. Preliminary study into the effect of processing on the mechanical integrity of bone allograft material

608

P48 Impact of metastatic axillary lymph node ratio on prognostic significance in stage IIIC (pN3) breast cancer

609

P48 Le carcinome neuroendocrine primitif cutané: 21 cas

610

P48 Le traitement des adénocarcinomes de lʹendomètre. ہ propos dʹune analyse rétrospective de 445 cas traités au centre François-Baclesse de Caen de 1980 à 1990

611

p48 Overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells

612

P48 Surgical treatment of early breast cancer — Moving towards breast conservation and immediate breast reconstruction

613

P48. Rates of change of spinal BMD in healthy women

614

P49 Lʹimportance de la lymphadénectomie pelvienne au cours du traitement du cancer de la prostate

615

P49 Molecular characterization of E2F1 and PSMB9 expression in breast cancer and correlation with poor prognosis and disease recurrence

616

P49 Predictors of recurrence after breast conservation treatment in 1668 women

617

P49 Radiothérapie hyperfractionnée (RTHF) dans le traitement des neuroblastomes (Nb), expérience de lʹinstitut Gustave-Roussy (IGR)

618

P49. Effects of menopause and anti-osteoporosis therapy on circulating collagen propeptides

619

P4-domination in minimal imperfect graphs Original Research Article

620

P4-laden graphs: A new class of brittle graphs

621

P4M: a parallel version of P3M

622

P4N4F7O−—the isoelectronic counterpart of P4N4F8

623

P4S10/dimethicone tandem: efficient reagent for thionation of various aromatic amides and esters

624

P4VPy–CuO nanoparticles as a novel and reusable catalyst: application at the protection of alcohols, phenols and amines

625

P5 Cpg island promoter hypermethylation in breast cancer development and progression

626

P5 Development of cell components for a 20 Ah, 12 V secondary zinc/air battery

627

P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer

628

P5 Hypothyroïdie sévère après chimioradiothérapie dʹun cancer du sein. Analyse de quatre cas

629

P5 Targeting heparan sulfation in breast cancer therapeutics

630

P5. Osteoporosis in coeliac disease

631

P50 Auditory Evoked Potential Suppression in Bipolar Disorder Patients With Psychotic Features and Their Unaffected Relatives

632

P50 Curiethérapie à haut débit de dose avec lʹapplicateur moulé vaginal de Chassagne dans le traitement des tumeurs gynécologiques

633

P50 event-related brain potential amplitude and suppression measurements recorded with subjects seated versus supine

634

P50 Prognostic value of apoptosis and survivin, bcl-2, p53 expression in breast cancer patients

635

P50 Radiothérapie classique et chimiothérapie concomitante par carboplatine et 5-fluorouracile de 75 carcinomes de stade III ou IV des voies aérodigestives supérieures (VADS)

636

P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia

637

P50 sensory gating in panic disorder

638

P50 Suppression among schizophrenia and normal comparison subjects: A methodological analysis

639

P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study

640

P50 Suppression in Children with Selective Mutism: a Preliminary Report

641

P50 Suppression in Individuals at Risk for Schizophrenia: The Convergence of Clinical, Familial, and Vulnerability Marker Risk Assessment

642

P50 suppression, prepulse inhibition, and startle reactivity in the same patient cohort suffering from posttraumatic stress disorder

643

P50 Ten year experience with needle-localized open breastbiopsy for non-palpable breast lesions: BIRADS classification and histopathologic correlation

644

P50 variations in Behçet’s patients without neurologic findings

645

P50. Regulation of differentiation of human bone marrow stromal cells into osteoblast-like cells by TGF-β and 1,25(OH)2D3

646

P50. Regulation of differentiation of human bone marrow stromal cells into osteoblast-like cells by TGF-β and 1,25(OH)2D3

647

P51 Axillary lymph node ratio and total number ofremoved lymph nodes

648

P51 Le choriocarcinome du testicule: à propos dʹun cas

649

P51 Predictive role of immunohistochemical cytokeratine assay (IHC-CK) in neoadjuvant setting: pilot study in 19 patients treated with TAC regimen

650

P51 Radiothérapie bifractionnée des glioblastomes multiformes de lʹadulte avec escalade de doses par une combinaison de photons et de protons. ہ propos de 23 malades traités au cyclotron de Harvard (Massachusetts General Hospital)

651

P51. Transforming growth factor-beta expression in regenerating deer antler

652

P52 Association radio-chimiothérapie concomitante préopératoire dans les cancers du rectum localement évolués

653

P52 Brisighella Heart Study: evaluation of compliance to therapy

654

P52 Le carcinome à cellules claires du larynx: à propos dʹun cas

655

P52 The axillary lymph node status (ALNS) of breast cancers by combined ER, PR and HER-2 expression: Triple positive tumours are more likely lymph node positive

656

P52 The intraoperative cytological evaluation of sentinellymph node in patients with breast cancer

657

P52. Ovariectomy causes profound bone loss from the tibiae but not the calvariae of rats

658

p53 Abnormality and Chromosomal Instability in the Same Breast Tumor Cells

659

p53 accumulation in the organs of low-dose X-ray-irradiated mice

660

p53 Activates the Mitochondrial Death Pathway and Apoptosis of Ventricular Myocytes Independent of de novo Gene Transcription

661

p53 Activation: A Case against Sir

662

P53 alterations are predictive of aggressiveness in ovarian carcinomas

663

p53 alterations in breast tumors in patients of Brazil

664

p53 and breast cancer

665

P53 AND Ki67 BIOMARKERS AS PROGNOSTIC FACTORS OF NON SMALL CELL LUNG CARCINOMA

666

P53 and Ki67 protein expression in ocular squamous cell carcinomas of dairy cattle

667

p53 and MDM2: Antagonists or Partners in Crime?

668

P53 and Nuclear Unrest: Biological Driver’s Suggesting Poor Prognosis in Anaplastic Wilm’s Tumor

669

p53 and p21/WAF-1 overexpressions in prostatic adenocarcinoma

670

p53 and PCNA Expression in Keratocystic Odontogenic Tumors Compared with Selected Odontogenic Cysts

671

P53 and Prognosis: New Insights and Further Complexity

672

P53 and radiation response. The impact of oncogene activation in œsophagus carcincoma treated by radiotherapy only

673

p53 and TGF-β in Development: Prelude to Tumor Suppression?

674

p53 as a target for the treatment of cancer

675

p53 autoantibodies from patients with head and neck cancer recognise common epitopes on the polypeptide chain of p53

676

p53 binding protein 1 foci as a biomarker of DNA double strand breaks induced by ionizing radiation

677

p53 binding protein 1 foci as a biomarker of DNA double strand breaks induced by ionizing radiation

678

p53 blocks RuvAB promoted branch migration and modulates resolution of Holliday junctions by RuvC

679

P53 but not cyclin E acts in a negative regulatory loop to control HER-2 expression in MCF-7 breast carcinoma cell line.

680

p53 but not p16INK4a induces growth arrest in retinoblastoma-deficient hepatocellular carcinoma cells

681

P53 Cancers du col utérin localement évolués. ہ propos de 383 cas

682

p53 codon 72 polymorphism and its association with bladder cancer

683

p53 codon 72 polymorphism and risk of cervical cancer in UK

684

P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study

685

p53 codon 72 polymorphism and urothelial cancer risk

686

p53 codon 72 polymorphism in nasopharyngeal carcinoma

687

p53 Codon 72 polymorphism is associated with occurrence of cervical carcinoma in the Chinese population

688

P53 Codon 72 polymorphisms: A case-control study of gastric cancer and potential interactions

689

p53 Contains Large Unstructured Regions in its Native State

690

p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms

691

p53 Enters the MicroRNA World

692

P53 Evaluation of ER, and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

693

p53 Exon 5 mutations in two cases of leukemic mantle cell lymphoma

694

p53 Exon 7 mutations as a predictor of poor prognosis in patients with colorectal cancer

695

p53 expression as a prognostic determinant in resected distal bile duct carcinoma

696

p53 expression in breast and endometrium during estrogen and tamoxifen treatment of surgically postmenopausal cynomolgus macaques

697

p53 expression in breast and endometrium during estrogen and tamoxifen treatment of surgically postmenopausal cynomolgus macaques

698

p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients

699

p53 expression in fallopian tube carcinomas

700

p53 expression in invasive pancreatic adenocarcinoma and precursor lesions

701

P53 Expression in Prostatic Cancer: An Immunohistochemical Study

702

P53 expression in synchronous colorectal cancer

703

p53 expression in synovial sarcoma and its association with prognostic factors

704

P53 expression in various types of hydropic placentas (through ploidy analysis as a complementary tool in diagnosis of samples)

705

p53 family members in myogenic differentiation and rhabdomyosarcoma development

706

p53 functional loss in a colon cancer cell line with two missense mutations (218leu and 248trp) on separate alleles

707

p53 gene alteration and protein expression in Iranian women with infiltrative ductal breast carcinoma

708

p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India

709

p53 gene mutation in cerebral primitive neuroectodermal tumor in Taiwan

710

p53 gene mutation in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder tumors and N-methyl-N-nitrosourea-induced colon tumors of rats

711

p53 gene mutation in thyroid carcinoma

712

p53 gene mutation, tumor p53 protein overexpression, and serum p53 autoantibody generation in patients with breast cancer

713

p53 gene mutations in Bowenʹs disease in Koreans: clustering in exon 5 and multiple mutations

714

P53 gene mutations in osteosarcomas in the dog

715

p53 gene mutations in rectal cancer associated with schistosomiasis japonica in Chinese patients

716

p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long term cell lines but may be acquired in acute myeloid leukemia cells in vitro

717

P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients

718

p53 genotypes and haplotypes associated with risk of breast cancer

719

p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway

720

P53 IHC Result as a Prognostic Tool in MDS

721

p53 immunoexpression: An aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?

722

p53 immunohistochemistry in bladder cancer: Combined analysis: a way to go?

723

p53 immunohistochemistry in bladder cancer—a new approach to an old question

724

p53 Immunohistochemistry of odontogenic keratocysts in relation to recurrence, basal-cell budding and basal-cell naevus syndrome

725

p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinoma

726

p53 immunoreactivity in breast cancer tissues does not deteriorate in stored paraffin sections

727

p53 in drug resistance in ovarian cancer

728

p53 in noncancerous bladder mucosa as a marker of disease recurrence in patients with superficial transitional cell carcinoma of the bladder

729

p53 in the Cytoplasm: A Question of Overkill?

730

p53 inactivating mutations in Chinese nasopharyngeal carcinomas

731

p53 Inhibits Strand Exchange and Replication Fork Regression Promoted by Human Rad51

732

p53 involvement in BRCA1-associated breast cancer

733

p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy

734

p53 is not involved in the overexpression of bax protein in the left ventricle of SHR

735

P53 Le rôle de la radiothérapie dans le traitement du cancer de lʹœsophage

736

p53 leans on its siblings

737

p53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis

738

p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines

739

p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity

740

p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats

741

p53 mutation as a potential cellular factor for tumor development in enzootic bovine leukosis

742

p53 mutation as a potential cellular factor for tumor development in enzootic bovine leukosis

743

p53 Mutation in epithelial ovarian carcinoma and borderline ovarian tumor

744

p53 Mutation Possibility and Food Dietary Containing Heavy Metals

745

p53 mutations and microsatellite instability in ovarian cancer: Yin and Yang

746

p53 mutations and overexpressions in Japanese breast cancer

747

p53 mutations and resistance to chemotherapy: A stab in the back for p73

748

p53 mutations are common in human papillomavirus type 38-positive non-melanoma skin cancers

749

P53 Mutations as a possible predictor of response to chemotherapy in metastatic colorectal cancers

750

p53 mutations in betel-associated oral cancer from Thailand

751

p53 mutations in bilateral breast carcinoma. Correlation with Ki-67 expression and the mean nuclear volume

752

p53 mutations in BRCA1-associated familial breast cancer

753

p53 mutations in BRCA1-associated familial breast cancer

754

p53 mutations in gastric cancers from Taiwan

755

p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine

756

p53 mutations predict non-small cell lung carcinoma response to radiotherapy

757

p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis

758

p53 overexpression and downregulation of inter-α-inhibitor are associated with hyaluronidase enhancement of TNF cytotoxicity in L929 fibroblasts

759

p53 overexpression in advanced-stage endometrial adenocarcinoma, , ,

760

P53 Overexpression in Bladder Urothelial Neoplasms New Aspect of World Health Organization/International Society of Urological Pathology Classification

761

p53 overexpression is a prognostic indicator in poorly differentiated, node negative and T1/T2 invasive ductal breast cancer patients

762

p53 pathway gene single nucleotide polymorphisms and chronic lymphocytic leukemia

763

p53 Pathway in Apoptosis Induced by All-Trans-Retinoic Acid in Acute Myeloblastic Leukaemia Cells

764

p53 plays a central role in UVA and UVB induced cell damage and apoptosis in melanoma cells

765

p53 point mutation enhanced by hepatic regeneration in aflatoxin B1-induced rat liver tumors and preneoplastic lesions

766

p53 polymorphism and cervical cancer

767

p53 polymorphism and cervical cancer

768

p53 polymorphism and risk of cervical cancer

769

p53 polymorphism in ovarian and bladder cancer

770

p53 polymorphism in ovarian and breast cancer

771

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

772

p53 Protein Accumulation and Presence of Visceral Metastasis Are Independent Prognostic Factors for Survival in Patients with Metastatic Inflammatory Breast Carcinoma

773

p53 protein accumulation in colorectal cancer tissue has prognostic value only in left-sided colon tumours

774

p53 protein accumulation, cancer multiplicity, and aldehyde dehydrogenase-2 genotype in Japanese alcoholic men with early esophageal squamous cell carcinoma

775

p53 protein accumulation, iodine-unstained lesions, and alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 genotypes in Japanese alcoholic men with esophageal dysplasia

776

p53 protein detection by the Western blotting technique in normal and neoplastic specimens of human endometrium

777

p53 Protein Expression and Its Relation to the Apoptotic Index in Prostate Adenocarcinoma

778

p53 protein expression in human breast cancer: an immunohistochemical study including correlation with steroid receptor status, proliferation indices, collagen type IV, laminin, C-erbB-2 oncoprotein and Cathepsin D

779

p53 protein expression in patients with hepatocellular carcinoma from the high incidence area of Guangxi, Southern China

780

p53 protein overexpression and chemosensitivity in breast cancer

781

p53 protein overexpression and p53 mutation analysis in patients with intestinal metaplasia of the cardia and Barrettʹs esophagus

782

p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer

783

p53 Regulates Hsp90β during arsenite-induced cytotoxicity in glutathione-deficient cells

784

p53 Regulation Orchestrates the TGF-β Response

785

p53 Requires an Intact C-Terminal Domain for DNA Binding and Transactivation

786

P53 Sentinel lymph node biopsy during prophylactic mastectomy: Is there an indication?

787

p53 stabilization is decreased upon NFκB activation: A role for NFκB in acquisition of resistance to chemotherapy

788

p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling

789

p53 tumour mutations predict response to therapy

790

p53 tumour suppressor gene and the tobacco industry

791

p53 tumour suppressor gene and the tobacco industry

792

p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive nonHodgkins lymphomas

793

P53. Immunofluorescent detection of oestrogen receptors (ER) suitable for use with avian bone

794

P53/MDM2 CO-EXPRESSION CORRELATES WITH THE TUMOUR DIFFERENTIATION IN ORAL SQUAMOUS CELL CARCINOMA – A RETROSPECTIVE STUDY AND A SYSTEMATIC REVIEW

795

P53/P21 Expression Increment as Predisposing Factor for Cancer Development in Hypertensive Patients in Al-Diwaniyah Province, Iraq

796

p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells

797

p53: A New Kingpin in the Stem Cell Arena

798

p53: Death Star

799

p53: Good Cop/Bad Cop

800

p53: Regular or super?

801

p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53

802

p53—An examination of sibling support in apoptosis control

803

p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer

804

P53-Deficiency directly revealed the non-threshold leukemogenesis by a single administration of relatively low-dose of methyl nitrosourea

805

p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA Damage

806

p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest

807

p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG

808

p53-dependent radioresistance in ovarian carcinoma cell lines

809

p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines

810

p53-Independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells

811

p53-independent induction of WAF1/Cip1 is correlated with osteoblastic differentiation by vitamin D3

812

p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages

813

p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer

814

p53-Mediated Transcriptional Activation: From Test Tube to Cell

815

p53—now it is needed for nerve regeneration

816

P53-participated cellular and molecular responses to irradiation are cell differentiation-determined in murine intestinal epithelium

817

P54 Association concomitante préopératoire de radiothérapie et de chimiothérapie dans le cancer du rectum: étude de la réponse histologique et de la conservation sphinctérienne. Série de 69 patients

818

P54 Curietherapie à haut débit de dose (HDD) dans les carcinomes bronchiques non à petites cellules classés T1N0M0

819

P54 Triple positive (ER+/PR+/HER-2+) breast carcinomas occur at a younger age than all other ER/PR/HER-2 breast cancer phenotypes

820

P54. Mechanisms of bone loss following liver transplantation

821

P55 Dose et volume dʹirradiation dans le séminome testiculaire de stade I: décroissance thérapeutique ou régression ?

822

P55 Facteurs pronostiques de tassement vertébral après irradiation de métastases vertébrales: méthodologie et résultats préliminaires

823

P55 Prognostic significance of bcl-2 expression in stage III breast cancer patients who received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

824

P55 Removal of sentinel lymph nodes with the highest and the 2nd highest radioactivity is essential to accurately predict the axillary status

825

P55. Bone turnover in men after cardiac transplantation

826

p55CDC/hCDC20 mutant induces mitotic catastrophe by inhibiting the MAD2-dependent spindle checkpoint activity in tumor cells

827

P56 Age dependent variability in interaction of hormone receptors and HER2 neu and its prognostic implication in early breast cancer: A retrospective analysis in South Indian women

828

P56 Cancer médullaire de la thyroïde. Expérience du centre dʹoncologie Ibn-Rochd

829

P56 More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolemia

830

P56 Radiothérapie conformationnelle des cancers du massif facial et des sinus de la face. Simulation virtuelle et dosimétrie 3D: expérience du centre Léon-Bérard

831

P56 Value of axillary dissection technique in combined treatment of Breast Cancer patients

832

P56. Bone mineral density in women with previous ankle fracture

833

p56lck Interactions Accelerate Autophosphorylation and Enhance Activity toward Exogenous Substrates

834

P57 Arcthérapie par électrons de la paroi thoracique après mastectomie

835

P57 HER-2/neu over-expression among Filipino patients with breast cancer: a 10 year review

836

P57 Ipsilateral breast tumor recurrence afterbreast-conserving therapy: A comparison of quadrantectomy versus lumpectomy in a single institution

837

P57 Logiciel médical avec imagerie intégrée

838

P57. A structural model for the ultrasonic assessment of cancellous bone

839

p57Kip2 is Induced by MyoD Through a p73-dependent Pathway

840

P58 Clinical treatment decision on local therapy inductal carcinoma in situ

841

P58 La prise en charge de la pathologie bénigne dans le service de carcinologie radiothérapie de Sfax

842

P58 Primary radiotherapy of early stage laryngeal carcinoma

843

P58. Fracture healing and alkaline phosphatase expression after low energy laser treatment

844

P59 Radiotherapy in non-Hodgkinʹs cutaneous lymphomas

845

P59 Résultats thérapeutiques des séminomes testiculaires à partir dʹune série de 56 patients

846

P59. Modulation of hydroxyapatite crystal growth: the role of albumin and endogenous matrix in enamel development

847

P5-free augmenting graphs and the maximum stable set problem Original Research Article

848

P6 Cancer du sein: pronostic après récidive locorégionale

849

P6 Glassy carbon capacitor stack

850

P6 Promoter methylation profiles and field defect in breast cancer

851

P6 S-phase of the diploid and aneuploid cell subpopulations in early (pT1) DNA-aneuploid breast cancers

852

P6. Biochemical bone markers in anorexia nervosa

853

P60 A prospective trial of intraoperative radiotherapy for breast cancer

854

P60 Lowering blood cholesterol in survivors of Myocardial infarction (MI): still a challenge

855

P60 Résultats thérapeutiques de lʹassociation chirurgie et curiethérapie dans le traitement des chéloïdes

856

P60 Traitement conservateur par irradiation du cancer du larynx limité à la glotte

857

P60. Influence of prior hysterectomy with and without oophorectomy upon spinal BMD in the perimenopause

858

P600 related to rule violation in an arithmetic task

859

P60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytes

860

P61 Comparaison de la dose reçue au niveau du rectum et de la vessie entre lʹapplicateur de Delouche et lʹapplicateur moulé cervicovaginal lors de la curiethérapie utérovaginale

861

P61 La curiethérapie endocavitaire vaginale à bas débit de dose (BDD), et la curiethérapie à haut débit de dose (HDD), dans le cancer de lʹendomètre: expérience du centre Francois-Baclesse de Caen

862

P61 The nature of the target in breast conservingradiotherapy using magnetic resonance imaging (MRI) tissue characterisation

863

P61. A logistical technical examination of mass population densitometry

864

p62 at the Crossroads of Autophagy, Apoptosis, and Cancer

865

P62 Le gliome intranasal de lʹadulte: une rareté et un problème nosologique. ہ propos dʹun cas et revue de littérature

866

P62 Sequencing of regional radiotherapy andchemotherapy does not compromise cytotoxic dose intensity in the ADEBAR-trial

867

P62 Traitement à visée curative du cancer de lʹœsophage non métastatique

868

p63 and Epithelial Metaplasia: A Gutsy Choice

869

P63 and Ki-67 Expression in Dentigerous Cyst and Ameloblastomas

870

P63 and Ki-67 expression in trophoblastic disease and spontaneous abortion

871

p63 and p73 are not required for the development and p53-dependent apoptosis of T cells

872

P63 and P73: Teammates or adversaries?

873

p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck

874

p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia

875

p63 is more sensitive and specific than 34βE12 to differentiate adenocarcinoma of prostate from cancer mimickers

876

p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis

877

P63 Pour une analyse économique des processus de production en radiothérapie: recherche des inducteurs de coûts dans deux services hospitaliers

878

p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis

879

P64 Carcinomes du nasopharynx et virus dʹEpstein-Barr

880

P64 Traitement des cancers indifférenciés du cavum (UCNT) dans le centre tunisien

881

P65 Dysfonctionnement thyroïdien après radiothérapie cervicale

882

p65 Homodimer activity in distal airway cells determines lung dysfunction in equine heaves

883

p65 Homodimer activity in distal airway cells determines lung dysfunction in equine heaves

884

P65 Maladie de Buschke-Lowenstein anorectale et vulvaire

885

p65-Dependent production of interleukin-1β by osteolytic prostate cancer cells causes an induction of chemokine expression in osteoblasts

886

P66 Maladie de Paget du sein. ہ propos de 30 cas

887

p66 Trp24 and Phe61 Are Essential for Accurate Association of HIV-1 Reverse Transcriptase with Primer/Template

888

p66shc and oxidative stress induced by post-ischemic reperfusion injury

889

P66shc regulates endothelial NO production and endothelium-dependent vasorelaxation: implications for age-associated vascular dysfunction

890

p66Shc: at the crossroad of oxidative stress and the genetics of aging

891

P67 Cancer du larynx: expérience du centre dʹoncologie Ibn-Rochd de Casablanca

892

P67 Lʹincidence de récidive sus-claviculaire chez les patientes atteintes de néoplasie du sein de stade Tl-2, ayant quatre ganglions atteints ou plus, traitées par chirurgie conservatrice et irradiation par champs tangentiels sans irradiation ganglionnair

893

P68 Le repositionnement des patients en radiothérapie de conformation. Expérience du centre hospitalier Lyon-Sud

894

P68 Place de la radiothérapie de contact dans le traitement des tumeurs du rectum

895

P680 (PD1PD2) and ChlD1 as alternative electron donors in photosystem II core complexes and isolated reaction centers

896

P680: what is it and where is it?

897

P69 Protonthérapie des angiomes choroïdiens compliqués

898

P69 Traitement des angiomes caverneux: approche radiochirugicale

899

P7 Expression of estrogen receptors alfa and beta andprogesterone receptor in invasive ductal and lobular breast cancer

900

P7 Improvements in lithium/CFx cells

901

P7 Survie après radiothérapie pour récidive de cancer du sein

902

P7 The CHEK2 1100delC mutation is not present in Korean patients with breast cancer tested for BRCA1 and BRCA2 mutation

903

P7. Architecture of the femoral neck in osteoarthritis

904

P70 Protonthérapie des tumeurs du système nerveux central et de la base du crâne. Expérience préliminaire du centre dʹOrsay

905

p70s6k is involved in the cytoprotective effect induced by IGF-1 administration during hypoxia-reoxygenation

906

P71 Association radio-chimiothérapie hyperfractionnée accélérée pour le traitement des carcinomes épidermoïdes du sinus piriforme T3. Résultats préliminaires

907

P72 Carcinomes de lʹoropharynx des sujets âgés

908

P73 Curietherapie de haut débit de dose (CHDD) endobronchique en territoire irradié: y a-t-il un bénéfice?

909

p73 mutations are not detected in sporadic and hereditary breast cancer

910

p73 mutations are not detected in sporadic and hereditary breast cancer

911

P74 Facteurs pronostiques dʹune série de 137 adénocarcinomes de lʹendomètre de stade clinique T1 UICC

912

p75 blockade—can it prevent neuronal death?

913

P75 Intérêt de lʹirradiation en conditions stéréotaxiques des métastases cérébrales: expérience de la Pitié-Salpêtrière

914

P76 Curietherapie postopératoire des cicatrices chéloïdes. ةtude rétrospective portant sur 47 cas

915

P8 Curietherapie virtuelle dans le traitement conservateur du cancer du sein

916

P8 Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas

917

P8 Potentiation of erythropoietin (EPO) action by membrane steroid receptor agonists

918

P8 The stress-controlled transport of lithium through the graphite electrode under the co-existence of two staged-phases

919

P8. ILIβ increases nitrix oxide and IL6 production in human intervertebral disc cells in vitro

920

P8. ILIβ increases nitrix oxide and IL6 production in human intervertebral disc cells in vitro

921

P84 Co-polyimide/Nanocrystalline Cellulose (NCC)-based Tubular Carbon Membrane: Effect of Drying Times for Carbon Dioxide Separation at Elevated Carbonization Temperature

922

P84 Co-Polyimide-based Tubular Carbon Membrane: Effect of Pyrolysis Temperature

923

P85, Optison microbubbles and ultrasound cooperate in mediating plasmid DNA transfection in mouse skeletal muscles in vivo

924

P85, Optison microbubbles and ultrasound cooperate in mediating plasmid DNA transfection in mouse skeletal muscles in vivo

925

P9 Effect of temperature on the performance of PMAN carbon anodes in 1 M LiPF6/EC-DMC solution

926

P9 Inhibition of P-glycoprotein by polyprenol in human breast cancer cells

927

P9 Relations among expression of Ki-67, p53, hormonalreceptors and traditional clinicopathological features in stage I and II breast cancer

928

P9 ةtude de phase I dʹirradiation peropératoire après quadrantectomie: rationnel et technique

929

P9. Treated hyperthyroidism: are the bones still at risk?

930

P901. The role of fine needle aspiration biopsy in breast lesions: analysis of series of 4110 cases

931

P902. ‘Late intensification therapy’ with or without peripheral blood progenitor cell transplant (PBPCT) in breast cancer larger than 3 cm and with 10 or more positive nodes

932

P903. Loss of heterozygosity in the 17821 region in breast cancer: clinical correlation

933

P904. Feasibility of adjuvant chemotherapy during skin expansion in mastectomized breast cancer patients underwent immediate reconstruction

934

P905. The influence of education on knowledge and accomplishment to breast cancer prevention modalities: data from 2889 questionnaires

935

P906. Tissue carcinoembrionic antigen and estrogen receptor status in breast carcinoma: a study in a series of 252 patients with long term follow-up

936

P907. Diagnostic value of US guided fine needle aspiration cytology in breast lesions

937

P908. A mathematical function fitted to the time intensity measurements in contrast uptaking breast lesions to separate benign from malignant lesions in dynamic breast MRI

938

P909. VNB and 5FU prolonged infusion in pretreated advanced breast cancer patients

939

P910. Introduction of sentinel node biopsy in breast cancer using lymphoscintigraphy and blue dye

940

P911. A simple technique for the correction of the inverted nipple

941

P912. Core biopsy in locally advanced breast cancer

942

P913. Breast cancer care in the elderly

943

P914. Family history of cancer in Italian women attending a breast unit: evaluation of criteria for referral to a genetics clinic and for BRCA1 and BRCA2 testing

944

P915. Attitudes toward genetic risk and testing of Italian women attending a breast unit

945

P916. Ocular metastases from breast cancer: a mono institutional review

946

P917. Taxol and fluorouracil as second line chemotherapy for metastatic breast cancer

947

P918. Breast cancer: response to primary chemotherapy and biological parameters (ER, PgR, Ki67)

948

P919. Subfractions of prostate specific antigen differ in serum of normal women and women with malignant and benign breast diseases

949

P920. Breast cancer with more than 3 positive nodes: adjuvant epirubicin followed by CMF +/- hormonotherapy. Preliminary results

950

P921. Management of mammary microcalcifications

951

P923. Neuroendocrine tumors of the breast

952

P925. Radiotherapy in breast cancer: our experience in elderly patients

953

P926. Two-phase early detection project in the No. 13 local health unit of the Veneto Region, Italy

954

P927. Analysis of BRCA-1 mutations in families from Southern Italy

955

P929. Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the regional treatment of locally advanced breast cancer

956

P930. Supportive care with disodic pamidronate in the treatment of breast cancer metastatic bone lesions

957

P96 Technique for Tissue Plastination in Preparing Long-Lasting Anatomical Specimens

958

P97/CDC-48: Proteostasis control in tumor cell biology

959

PA 66 spur gear durability improvement with tooth width modification

960

PA catheter-guided therapy does not benefit critically ill patients

961

PA/pKa equalization and the prediction of the hydrogen-bond strength: A synergism of classical thermodynamics and structural crystallography

962

PA6 and Kevlar fiber reinforced isotactic polypropylene: Structure, mechanical properties and crystallization and melting behavior

963

PAA influence on chitosan membrane calcification

964

PAA polymerized downstream of a high pressure DBD plasma

965

PAA/imidazol-based proton conducting polymer electrolytes

966

PAA-assisted synthesis of CaCO3 microcrystals and affecting factors under microwave irradiation Original Research Article

967

Paan chewing as a risk factor for hepatocellular carcinoma

968

Paan chewing as a risk factor for hepatocellular carcinoma – Authorsʹ reply

969

Paan Use in South-Eastern Iran: The Associated Factors

970

PAA-supported Hantzsch 1,4-dihydropyridine ester: an efficient catalyst for the hydrogenation of α,β-epoxy ketones

971

Pablo Lavados: improving stroke care in Chile

972

Pablo Neruda as the Place-maker: An Ecocritical Enquiry of ‘Place’ in Neruda’s Selected Poems

973

974

PAC activity vs by-product precursors in water disinfection

975

PAC learning in non-linear FIR models

976

PAC spectrometer for condensed matter investigation

977

PAC spectrometer for condensed matter investigation

978

PAC studies with LSO scintillation crystals

979

PAC studies with LSO scintillation crystals

980

PAC study of Ni-irradiated Sb films

981

PAC with high content of Al13 polymer prepared by electrolysis with periodical reversal of electrodes

982

PAC-1 Activates Procaspase-3 in Vitro through Relief of Zinc-Mediated Inhibition

983

PAC1 receptor (ADCYAP1R1) genotype is associated with PTSDʹs emotional numbing symptoms in Chinese earthquake survivors

984

PACAP expression and distribution in human breast cancer and healthy tissue

985

PACAP Induce Neurite Outgrowth in Cultured Trigeminal Ganglion Cell and Recovery of Corneal enitivity After Flap urgery in Rabbit Original Reearch Article

986

PACAP(6–38) inhibits the growth of prostate cancer cells

987

PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells

988

PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells

989

Pace of the genomics revolution hots up

990

Pace Panini: Towards a word-based theory of morphology : Alan Ford, Rajendra Singh and Gita Martohardjono, New York: Lang, 1997. Xiv + 149 Sfr. 49000 (hb.)

991

Pace versus type: the effect of economic growth on unemployment and wage patterns

992

PACE+: Interactive communication technology for behavior change in clinical settings

993

994

Paced escape-paced capture bigeminy

995

Paced skeletal muscle for dynamic cardiomyoplasty

996

Paced visual serial addition test in multiple sclerosis

997

PACEM: a new concept for high avalanche-ion blocking

998

PACEM: a new concept for high avalanche-ion blocking

999

Pacemaker After Transcatheter Aortic Valve Replacement: Unexpected, But Not Infrequent Outcome

1000

Pacemaker and network mechanisms of rhythm generation: Cooperation and competition

بازگشت